BridgeMD
New treatment option for Social Anxiety Disorder
Official title Very Brief Exposure: Development of a Novel Exposure Modality for Social Anxiety Disorder in Transition-Age Youth
ClinicalTrials.gov ID: NCT06526260
What this study is testing
- What it's testing
- The goal of this clinical trial is to identify the circuit activations by very brief exposure (VBE) among youth with social anxiety disorder (SAD) in order to develop a novel intervention for those with SAD. The secondary objectives of this study are to measure the effect of VBE on subjective fear ratings, and participants' awareness and tolerance of the exposure stimuli.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 22. Healthy volunteers may be eligible.
You may be able to join if
- Patient Population
- Males and females aged 16-22. This age range corresponds with our prior studies of very brief exposure (VBE) in Specific Phobia and will include...
- Youth with a Diagnostic and Statistical Manual of Mental Disorders (DSM-5) diagnosis of Social Anxiety Disorder (SAD) on Kiddie Schedule for...
- Healthy Population
- Male and female youth aged 16-22.
You likely can't join if
- Patient Population
- Primary language other than English or Spanish.
- Active suicidality on the Colombia-Suicide Severity Scale (plan, intent, or behavior)
- Ferromagnetic implants (e.g., pacemaker), metal braces, retainers, tattoos or permanent make-up with metallic content, transdermal medicinal patches...
- Current psychoactive medication.
- Lifetime diagnosis of: obsessive-compulsive disorder (OCD), psychotic, bipolar, autism spectrum disorder, intellectual disability on the KSADS-COMP...
See the full eligibility criteria
- Patient Population
- Males and females aged 16-22. This age range corresponds with our prior studies of very brief exposure (VBE) in Specific Phobia and will include older adolescents while minimizing potential developmental effects on...
- Youth with a Diagnostic and Statistical Manual of Mental Disorders (DSM-5) diagnosis of Social Anxiety Disorder (SAD) on Kiddie Schedule for Affective Disorders and Schizophrenia for School-Aged Children, Computerized...
- Healthy Population
- Male and female youth aged 16-22.
- Parents Parent/caregiver of all ages, no restrictions who are fluent in either English or Spanish.
- Patient Population
- Primary language other than English or Spanish.
- Active suicidality on the Colombia-Suicide Severity Scale (plan, intent, or behavior)
- Ferromagnetic implants (e.g., pacemaker), metal braces, retainers, tattoos or permanent make-up with metallic content, transdermal medicinal patches that cannot be removed.
- Current psychoactive medication.
- Lifetime diagnosis of: obsessive-compulsive disorder (OCD), psychotic, bipolar, autism spectrum disorder, intellectual disability on the KSADS-COMP or NetSCID.
- Any serious neurological or medical conditions (e.g., Lupus, cancer, human immunodeficiency virus positive (HIV+)) as reported by potential participants.
- Current Post-Traumatic Stress Disorder (PTSD) diagnosis.
- Current severe substance abuse (except tobacco/nicotine).
- Pregnancy, as determined by the participant's self-report prior to the magnetic resonance imaging (MRI) scan.
- Healthy Population
- Primary language other than English or Spanish.
- Lifetime disorders: any anxiety disorders, OCD, psychotic, bipolar, autism spectrum disorder, intellectual disability; any psychiatric disorder in the past 2 years
- Current depression disorder.
- Active psychiatric disorder in the past 2 years.
- Serious neurological or medical conditions.
- Current psychoactive medication.
- Ferromagnetic implants (e.g., pacemaker), metal braces, retainers, tattoos or permanent make-up with metallic content, transdermal medicinal patches that cannot be removed.
- Active suicidality on the Colombia-Suicide Severity Scale (plan, intent, or behavior).
- Pregnancy, as determined by the participant's self-report prior to the MRI scan.
- Parents Primary language other than English or Spanish.
The study team makes the final eligibility decision.
Where it's taking place
- Los Angeles, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 22 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Los Angeles, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.